Tobacco Intensive Motivational and Estimate Risk

NCT03583203 | Completed

• 1 other identifier: PI16/0082
• Study Type: interventional
• Target: 230
• Locations: 1 country
• Sites: 1

Brief Summary

Randomized, open label, prospective study with a 12-month follow-up period. The primary objective evaluates the effectiveness of an intensive anti-smoking programme that informs patients of their individual risk of lung damages and the possibilities of prevention. The main measurement will be having given up smoking in month 12, measurement of self-reported abstinence on the 7 previous days and confirmed by a CO-oximeter test\< 10 ppm, between the intervention and control group. A total of 9 urban and rural mental health centres will participate in the study. The intervention group will undergo spirometry and presence and the degree of respiratory obstruction will be assessed. Participants will be given individual information to generate a motivational message about the possibilities of prevention and the information will be maintained for three months by sending text messages (SMS) to their mobile phones. The efficacy of the method and the pulmonary damage variables will be evaluated: smoking cessation at the end of follow-up will be confirmed by cooximetry, and the COPD diagnosis and the severity of the staging for disease will be assessed

Conditions

Severe Mental Disorder; Smoking Cessation; COPD

Keywords

schizophrenia; bipolar disorder; tobacco; COPD

Outcome Measures

Primary Outcomes (2)

• Smoking cessation

  Self-reported abstinence over the previous 7 days, confirmed by cooximetry with expired CO \<10 ppm

  12 months

• COPD diagnosis

  Presence of COPD and staging and percentage of forced expiratory volume at one second (FEV1) compared with expected level

  12 month

Study Arms (2)

Experimental Group

EXPERIMENTAL

This group will include personalized information about lung damage. After evaluating their COPD, the patients will be informed about its existence it so and staging. Depending on the damage found, the generation of motivation will focus on the different prevention methods. Likewise, after the motivation level is set, the patients will be offered the option of treatment and regular follow-up. The intervention will be strengthened by motivational messages, half of which are linked to the possibilities of preventing respiratory damage, sent to the patient's mobile phone via SMS during the 3 months after the face-to-face intervention. Patients without mobile phones will receive a call on their phone to convey the same messages.

Device: personalized information about lung damage

Control Group

NO INTERVENTION

The control intervention lasts 30 minutes and will be structured around the 5 A's technique (Ask, Advice, Assess, Assist and Arrange).

Interventions

personalized information about lung damage DEVICE

Chronic obstructive pulmonary disease (COPD) will be evaluated using spirometry. Based on this value, a motivational message about prevention will be issued for the intervention group, which will be reinforced by individualized text messages over a period of 3 months

Experimental Group

Eligibility Criteria

• Age: 40 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged between 40 and 70
• Confirmed diagnosis of Bipolar Disorder or Schizophrenia according to Diagnostic and Statistical Manual of Mental Disorder IV (DSM-IV-TR)
• Active smokers who currently consume at least 10 cigarettes a day, with a cumulative consumption of 10 packets/year or more.

You may not qualify if:

• Previous respiratory diagnosis of: asthma, cystic fibrosis, tuberculosis, simple chronic bronchitis, restrictive pulmonary disease or bronchiectasis
• Acute respiratory symptoms
• Heart disease or advanced oncological processes
• Existence of a pathology which makes it advisable not to perform spirometry (recent pneumothorax, recent thoracic or abdominal surgery, aortic aneurysm, unstable angulation, retinal detachment, facial hemiparesis or oral/dental problems)
• Patients who, due to their intellectual disability or mental pathology, do not understand or cannot be forced to perform spirometry
• Clinical instability with results of over 14 points on the Hamilton Depression Rating Scale (HDRS), a Young Mania Rating Scale (YMRS) of over 6 or a Positive and Negative Syndrome Scale (PANSS) of over 70

Sponsors & Collaborators

• Hospital Universitario Reina Sofia de Cordoba: lead
• Instituto de Salud Carlos III: collaborator

Study Sites (1)

Fernando Sarramea Crespo

Córdoba, 14004, Spain

Location

Related Publications (1)

• Jaen-Moreno MJ, Feu N, Redondo-Ecija J, Montiel FJ, Gomez C, Del Pozo GI, Alcala JA, Gutierrez-Rojas L, Balanza-Martinez V, Chauca GM, Carrion L, Osuna MI, Sanchez MD, Caro I, Ayora M, Valdivia F, Lopez MS, Poyato JM, Sarramea F. Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER-): study protocol for a randomized controlled trial. Trials. 2019 Jan 14;20(1):47. doi: 10.1186/s13063-018-3139-9.

  PMID: 30642365 DERIVED

MeSH Terms

Conditions

Mental Disorders; Smoking Cessation; Pulmonary Disease, Chronic Obstructive; Schizophrenia; Bipolar Disorder

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Schizophrenia Spectrum and Other Psychotic Disorders; Bipolar and Related Disorders; Mood Disorders

Study Officials

• Fernando Sarramea Crespo, Phd

  Hospital Universitario Reina Sofia Cordoba

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 28, 2018
• First Posted: July 11, 2018
• Study Start: July 12, 2018
• Primary Completion: December 1, 2018
• Study Completion: December 31, 2019
• Last Updated: January 9, 2020

Record last verified: 2020-01

Locations

ES (1)